Two-Sample Mendelian Randomization Study Examining the Interconnections Among Hypertension, Coronary Artery Disease, and Gastric Cancer with Additional Clinical Insights - Top-Institutions - MDSpire

Two-Sample Mendelian Randomization Study Examining the Interconnections Among Hypertension, Coronary Artery Disease, and Gastric Cancer with Additional Clinical Insights

  • By

  • Qian Ma

  • Ya-Fei Kong

  • Ai-Li Li

  • Li-Na Song

  • Yun-Meng Tian

  • April 21, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Harvard Medical School
    Harvard Medical School

    Boston, MA

    Key Differentiators

    • Cardiology
    • Oncology
    • Genetic Epidemiology
    • Biostatistics

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Oncology
    • Genomic Medicine

  • #3

    University of Cambridge
    University of Cambridge

    Cambridge, UK

    Key Differentiators

    • Genetic Epidemiology
    • Cardiology
    • Oncology

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Oncology
    • Genomic Medicine

  • #5

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Oncology
    • Genetic Epidemiology
    • Cancer Prevention

Original Source(s)

Two-Sample Mendelian Randomization Study Examining the Interconnections Among Hypertension, Coronary Artery Disease, and Gastric Cancer with Additional Clinical Insights

  • by Qian Ma, Ya-Fei Kong, Ai-Li Li, Li-Na Song, Yun-Meng Tian

  • April 21, 2026

Related Content

Comparative study of midterm outcomes between Roux-en-Y gastric bypass (RYGB), diverted one-anastomosis gastric bypass (D-OAGB), and one anastomosis gastric bypass (OAGB)

Visit-to-visit blood pressure variability and cardiovascular outcomes: a systematic review and dose-response meta-analysis

Cardiometabolic factors’ and cardiovascular risk in young adult cancer survivors: evidence from real-world data